DexCom Inc (DXCM) stock
DXCMNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 22/3030% below fair value
$80.19−2.33 (-2.82%)
Close on Nov 19, 2026Market cap $29.91BP/E 31.6Yield –
DexCom net income
Net income is the profit left for shareholders after every expense, interest and tax.
DexCom's net income for the twelve months ending Sep 30, 2026 was $991.00M, up 37.5% year over year. For fiscal 2025 it was $836.30M, up 45.1% from the year before. The highest annual figure on record is $836.30M in fiscal 2025.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $836.30M | +45.1% |
| FY2024 | Dec 31, 2024 | $576.20M | +6.4% |
| FY2023 | Dec 31, 2023 | $541.50M | +58.7% |
| FY2022 | Dec 31, 2022 | $341.20M | +57.3% |
| FY2021 | Dec 31, 2021 | $216.90M | -60.5% |
| FY2020 | Dec 31, 2020 | $549.70M | +443.7% |
| FY2019 | Dec 31, 2019 | $101.10M | – |
| FY2018 | Dec 31, 2018 | -$127.10M | – |
| FY2017 | Dec 31, 2017 | -$50.20M | – |
| FY2016 | Dec 31, 2016 | -$65.60M | – |
| FY2015 | Dec 31, 2015 | -$57.60M | – |
| FY2014 | Dec 31, 2014 | -$22.40M | – |
| FY2013 | Dec 31, 2013 | -$29.80M | – |
| FY2012 | Dec 31, 2012 | -$54.50M | – |
| FY2011 | Dec 31, 2011 | -$44.70M | – |
| FY2010 | Dec 31, 2010 | -$55.20M | – |
| FY2009 | Dec 31, 2009 | -$53.52M | – |
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $275.10M | -3.1% |
| Q2 FY2026 | Jun 30, 2026 | $249.10M | +38.5% |
| Q1 FY2026 | Mar 31, 2026 | $199.50M | +89.3% |
| Q4 FY2025 | Dec 31, 2025 | $267.30M | +76.2% |
| Q3 FY2025 | Sep 30, 2025 | $283.80M | +110.8% |
| Q2 FY2025 | Jun 30, 2025 | $179.80M | +25.3% |
| Q1 FY2025 | Mar 31, 2025 | $105.40M | -28.0% |
| Q4 FY2024 | Dec 31, 2024 | $151.70M | -40.8% |
| Q3 FY2024 | Sep 30, 2024 | $134.60M | +11.5% |
| Q2 FY2024 | Jun 30, 2024 | $143.50M | +23.8% |
| Q1 FY2024 | Mar 31, 2024 | $146.40M | +201.2% |
| Q4 FY2023 | Dec 31, 2023 | $256.30M | +179.2% |
| Q3 FY2023 | Sep 30, 2023 | $120.70M | +19.3% |
| Q2 FY2023 | Jun 30, 2023 | $115.90M | +127.7% |
| Q1 FY2023 | Mar 31, 2023 | $48.60M | -50.1% |
| Q4 FY2022 | Dec 31, 2022 | $91.80M | – |
| Q3 FY2022 | Sep 30, 2022 | $101.20M | +15.9% |
| Q2 FY2022 | Jun 30, 2022 | $50.90M | -35.1% |
| Q1 FY2022 | Mar 31, 2022 | $97.30M | +72.2% |
| Q4 FY2021 | Dec 31, 2021 | -$5.30M | -101.3% |
| Q3 FY2021 | Sep 30, 2021 | $87.30M | +20.9% |
| Q2 FY2021 | Jun 30, 2021 | $78.40M | +69.3% |
| Q1 FY2021 | Mar 31, 2021 | $56.50M | +183.9% |
| Q4 FY2020 | Dec 31, 2020 | $411.30M | +343.7% |
| Q3 FY2020 | Sep 30, 2020 | $72.20M | +57.6% |
| Q2 FY2020 | Jun 30, 2020 | $46.30M | – |
| Q1 FY2020 | Mar 31, 2020 | $19.90M | – |
| Q4 FY2019 | Dec 31, 2019 | $92.70M | – |
| Q3 FY2019 | Sep 30, 2019 | $45.80M | -1.7% |
| Q2 FY2019 | Jun 30, 2019 | -$10.50M | -134.8% |
| Q1 FY2019 | Mar 31, 2019 | -$26.90M | – |
| Q4 FY2018 | Dec 31, 2018 | -$179.70M | – |
| Q3 FY2018 | Sep 30, 2018 | $46.60M | – |
| Q2 FY2018 | Jun 30, 2018 | $30.20M | +941.4% |
| Q1 FY2018 | Mar 31, 2018 | -$24.20M | – |
| Q4 FY2017 | Dec 31, 2017 | -$9.40M | – |
| Q3 FY2017 | Sep 30, 2017 | -$2.00M | – |
| Q2 FY2017 | Jun 30, 2017 | $2.90M | – |
| Q1 FY2017 | Mar 31, 2017 | -$41.70M | – |
| Q4 FY2016 | Dec 31, 2016 | -$7.40M | – |
See a number that looks wrong?